Securities code:603520
Public Notice of the Draft Environmental Impact Assessment for Jiangxi Sitali Pharmaceutical Co., Ltd.’s Annual Production Capacity of 10 Tons of (-)-PP/Toluene Solution, 16.6 Tons of (±)-PP·PNBA, and 16.8 Tons of (-)-PP·AcPhe
2026-05-09
To safeguard the public’s rights to information, participation, expression, and oversight in environmental protection, and in accordance with the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), the following information is hereby made public to solicit opinions related to the environmental impacts of this construction project.
I. Online link to the full draft Environmental Impact Report for public comment, as well as methods and channels for reviewing the hard copy of the report
1. Full-text online link to the draft Environmental Impact Report for public comment (file shared via Baidu Netdisk: Link: https://pan.baidu.com/s/1osuiY-ab7tZvz-o8CbijJg Extraction code: junr)
2. Methods and channels for consulting the paper report
Jiangxi Sitaili Pharmaceutical Co., Ltd. (Address: North side of Wuyi Road, Salt Chemical Base, Zhangshu City, Jiangxi Province; geographic coordinates: 115°37′1.31″ E, 28°01′24.07″ N).
II. Scope of Public Consultation
The public consultation is open to citizens, legal entities, and other organizations within the scope of the environmental impact assessment for this project, who are invited to submit their opinions and suggestions on the environmental impact assessment and environmental protection measures. Citizens, legal entities, and other organizations outside the scope of the environmental impact assessment are also welcome to offer their valuable input.
III. Online Link to the Public Opinion Form
Link: https://pan.baidu.com/s/1swYcUYLsAspZ8VST2okVaA
Extraction code: thwv
IV. Methods and Channels for Public Submission of Comments
Members of the public who have any suggestions or comments regarding the environmental impact assessment and environmental protection measures for this project are requested to download and complete the “Public Opinion Form for Environmental Impact Assessment of Construction Projects” via the online link provided above, and to submit the completed form by mail, fax, or email to the project proponent as follows.
Construction Entity: Jiangxi Sitaili Pharmaceutical Co., Ltd.
Contact: Zhao Dongdong; Contact Number: 18355469059
Address: North side of Wuyi Road, Salt Chemical Base, Zhangshu City, Jiangxi Province.
Email: 793247642@qq.com.
V. Period for Public Submission of Comments
Within 10 working days from the date of public notice.
Jiangxi Sitaili Pharmaceutical Co., Ltd.
May 9, 2026
Next page
Next page
Related news
Copyright © Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved.
Powered by www.300.cn
Wap
CONTACT US
Tel: 0576-87718628 / 021-37916067
E-mail: sales@starrypharma.com
Zhejiang Starry Pharmaceutical Co., Ltd.
Add: No.l Starry Road of Xianju, Modern IndustriaL, Centralization Zone, Xianju, Zhejiang, China
Shanghai Starry Pharmaceutical Co., Ltd.
Add: No.500 Maoye Road,Jinshan District 201506, Shanghai city, China
Zhejiang Taizhou Hisyn Pharmaceutical Co., Ltd.
Add: Chemical and Medical Raw Materials Base, Linhai Park, Zhejiang, China
Jiangxi Starry Pharmaceutical Co., Ltd.
Add: North of the Wuyl Road,Salt chemical Base, Zhangshu, Jiangxi, 331200, P.R.China
Imax Diagnostic Imaging Limited
Add: Phoenix House, Room 137 Monahan Road, CorkT12H1XY Republic of lreland
E-mail:info@imaxdiagnostic.com
Tel: 00353 21 451 9990
REQUEST A QUOTE